• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percent of Office of Compliance (OC) intra- and inter-Office eConsults completed on time during the month

Dictionary: CDRH uses the internal expert consultation process to acquire information and analysis on issues related to medical devices. Intra- and inter-office consultations are completed for a variety of work products requiring expertise within and across CDRH offices, including premarket device submissions, post-approval studies, and compliance and enforcement actions. Inter-office eConsults are used to facilitate the exchange of scientific information and staff expertise across CDRH, critical to making well-supported regulatory decisions. eConsult is the system CDRH uses to manage and monitor expert consult requests.

Data is current as of September 30, 2013

Fiscal Year - 2011

Skip graphic and jump to text data

TimeTargetPercent
Oct 20108581
Nov 20108587
Dec 20108585
Jan 20118587
Feb 20118592
Mar 20118590
Apr 20118595
May 20118588
Jun 20118590
Jul 20118585
Aug 20118591
Sep 20118592

FY 2011 Overall: 89%

Number of OC intra- and inter-Office eConsults completed on time during the month

Fiscal Year - 2011
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2010N/A147
Nov 2010N/A114
Dec 2010N/A148
Jan 2011N/A127
Feb 2011N/A157
Mar 2011N/A188
Apr 2011N/A199
May 2011N/A156
Jun 2011N/A289
Jul 2011N/A183
Aug 2011N/A217
Sep 2011N/A175

FY 2011 Total: 2,100

Total number of OC intra- and inter-Office eConsults completed during the month

Fiscal Year - 2011
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2010N/A181
Nov 2010N/A131
Dec 2010N/A175
Jan 2011N/A146
Feb 2011N/A171
Mar 2011N/A208
Apr 2011N/A209
May 2011N/A177
Jun 2011N/A321
Jul 2011N/A215
Aug 2011N/A238
Sep 2011N/A190

FY 2011 Total: 2,362

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.